Skip to main content
. 2011 Oct;30(10):682–689. doi: 10.5732/cjc.011.10188

Figure 2. Overall survival (full analysis set) In Chinese patients with metastatic colorectal cancer treated with either bevacizumab plus mIFL or mIFL alone.

Figure 2.

mIFL, modified irinotecan, leucovorin bolus, and 5-fluorouracil intravenous infusion.